BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Resources | Government Scientific Source - ECPv6.15.16//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://resources.govsci.com
X-WR-CALDESC:Events for Resources | Government Scientific Source
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20160313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20161106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20170312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20171105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20170101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181023T100000
DTEND;TZID=America/New_York:20181023T110000
DTSTAMP:20260611T103322
CREATED:20180906T192102Z
LAST-MODIFIED:20181025T174704Z
UID:2646-1540288800-1540292400@resources.govsci.com
SUMMARY:Promega: A Multi-Modal Assay for Quantitating and Interpreting Changes in Autophagic Flux
DESCRIPTION:This webinar is in collaboration with Aurelia Bioscience\, Nottingham\, UK. \nMonitoring autophagy using imaging or western blotting methods can be cumbersome\, low-throughput and subjective. Learn about a new LC3 reporter assay with three modalities (plate-reader based\, imaging and blotting) to help scale up your autophagy analysis with confidence. \nJoin us live to share your challenges with autophagy assays and test your knowledge of the pathway. \nWATCH ON DEMAND \nADDITIONAL WEBINAR INFORMATION: \nAre you studying autophagy or just getting started and want a simple\, add-mix-measure assay? Are you struggling to distinguish autophagy stimulation from late-phase pathway inhibition? Are you screening a large number of compounds and need a quantitative\, scalable assay? \nWhile imaging and western blotting are useful approaches for studying autophagy\, they can be challenging to interpret and have limited quantitative power. The new Autophagy LC3 HiBiT Reporter Assay enables you to unambiguously discern autophagy inducers from inhibitors with a quantitative\, plate-reader based readout. Implementing NanoBiT® and HaloTag®-based technology\, our autophagy reporter also allows for imaging and HiBiT blotting modalities to confirm mechanism of action as autophagy modulation\, and to discern early- versus late-phase pathway inhibition. \nJoin this live webinar to learn how the Autophagy LC3 HiBiT Reporter Assay can simplify your autophagy research. You’ll also hear about how Dr. Gary Allenby\, CSO and founder of Aurelia Biosciences\, benchmarked this autophagy assay against other assays for performance in high-throughput screening formats. \nPRESENTERS: DAN LAZAR\, PhD AND GARY ALLENBY\, PhD \nDr. Dan Lazar received his Ph.D. in biological chemistry from the University of Michigan and then completed a postdoctoral fellowship focused on cell signaling at Warner Lambert/Parke-Davis.  Subsequently\, he was a Team Leader and Senior Scientist at Eli Lilly within the metabolic disease drug-discovery area for well over a decade where he gained extensive experience in the development\, validation and implementation of cell-based and biochemical assays for drug discovery.  As a Group Leader and Senior Research Scientist at Promega\, Dan and his colleagues are principally focused on delivering novel cell-based assays for the quantitative assessment of various aspects of cell health to assist academic and industrial investigators. \nDr. Gary Allenby has a Ph.D. in reproductive toxicology\, and studied the pharmacology of retinoid biology as a post-doc at Hoffmann La Roche\, USA. He returned to the UK in 1995 to join the Lead Generation group at Glaxo Wellcome. There he developed cell-based assays for high throughput screening and worked with vendors to validate new technologies for screening and automated HTS. In 2000\, he joined the Hit Identification group at AstraZeneca\, developing assays for respiratory and inflammatory disease while continuing to work with vendors and automated assays. \nIn 2011\, Dr. Allenby became a founding entrepreneur of Aurelia Bioscience\, a pre-clinical contract research organization located in Nottingham\, UK. Aurelia Bioscience focuses on developing and implementing innovative cell-based assays for screening\, and collaborate with vendors to deliver value-adding data for drug discovery purposes.
URL:https://resources.govsci.com/event/promega-a-multi-modal-assay-for-quantitating-and-interpreting-changes-in-autophagic-flux/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181016T110000
DTEND;TZID=America/New_York:20181016T120000
DTSTAMP:20260611T103322
CREATED:20180904T161256Z
LAST-MODIFIED:20181213T133243Z
UID:2611-1539687600-1539691200@resources.govsci.com
SUMMARY:Agilent: Strategies to Avoid the Hidden Dangers of Suboptimal Sample Preparation and Simplify Your Workflow Simultaneously
DESCRIPTION:Summary \nA typical laboratory workflow comprises of sample collection\, sample preparation\, introduction to the instrument\, analysis\, data review\, and finally\, data reporting\, where sample preparation has always been considered the bottleneck and rate-limiting step. Current advanced instrumentation greatly increase your capability to analyze various samples\, considering the required sensitivity\, selectivity\, reliability\, and feasibility of complex sample testing. Therefore\, the sample preparation step has been minimized to reduce time\, cost\, and complexity\, improve the universal applicability\, and it has been reduced to be just good enough. \nThere are several hidden dangers in sub-optimal sample preparation\, such as wasted time\, instrument maintenance/failure issues\, and inaccurate data\, that can arise and affect your overall success. These hidden dangers can be eliminated or greatly minimized by proper sample preparation workflow strategies. This improvement can be realized without having to retrain your scientist\, making large capital expenditures\, or having to rewrite your standard operating procedures (SOPs).  The following Webinar will discuss how various samples with high lipid content are prepared with a simplified sample prep workflow utilizing Captiva EMR-Lipid. \nWATCH ON DEMAND \nView Whitepaper \n\n\n\n\n\n\n\nParticipants will learn: \n\nHow to minimize the hidden dangers of sub-optimal sample preparation\nA simplified workflow for complex samples with high lipid content\nAn understanding of the key applications where Captiva EMR—Lipid can maximize results and boost productivity\n\nWho Should Attend: \n\nLab Managers of contract\, government\, or QA/QC labs\nAnalytical chemists who develop methods for biological or food samples\nGraduate students and post-docs working on environmental\, pharmaceutical\, forensic\, or food analyses\n\nSpeakers \nGolnar Javadi\nTechnical Support Applications Engineer\nAgilent Technologies \n  \nAlex Ucci\nTechnical Support Applications Engineer\nAgilent
URL:https://resources.govsci.com/event/agilent-strategies-to-avoid-the-hidden-dangers-of-suboptimal-sample-preparation-and-simplify-your-workflow-simultaneously/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/09/wileymultiregoctober.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181011T120000
DTEND;TZID=America/New_York:20181011T130000
DTSTAMP:20260611T103322
CREATED:20181004T151430Z
LAST-MODIFIED:20181004T151430Z
UID:3031-1539259200-1539262800@resources.govsci.com
SUMMARY:QIAGEN: What's the 'Plus' in QuantiFERON-TB Gold Plus?
DESCRIPTION:Join Dr. Masae Kawamura for an updated review of QuantiFERON-TB Gold Plus \nQuantiFERON-TB Gold Plus is approaching the first anniversary of its release to the US market. This milestone year has also been marked by a broad shift in global guidance towards TB blood testing for populations at increased risk for TB. The QFT-Plus test features innovative CD8 T cell technology that provides clinicians with a more comprehensive picture of a patient’s immune response to TB. Recent publications continue to demonstrate the benefits of QFT-Plus technology for at-risk patient populations – including studies of test efficacy for contact investigation\, healthcare worker screening and immunocompromised patients.  \nJoin Dr. Masae Kawamura for a dynamic discussion of the latest scientific advancements in TB testing and CD8 technology\, including a review of recent publications and a discussion of case scenarios applying the insights of QFT-Plus.  \nDisclaimer: QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment\, radiography\, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to-date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com. The performance of the USA format of the QFT-Plus test has not been extensively evaluated with specimens from individuals who have impaired or altered immune functions\, such as those who have HIV infection or AIDS or those who have transplantation managed with immunosuppressive treatment or others who receive immunosuppressive drugs (e.g.\, corticosteroids\, methotrexate\, azathioprine\, cancer chemotherapy) \nCan’t make it? Don’t worry! Register and you’ll receive a link to the webinar recording! \nREGISTER HERE \nPresenter:\nMasae Kawamura\, M.D. Senior Director\, Medical & Scientific Affairs – TB Diagnostics\, QIAGEN
URL:https://resources.govsci.com/event/qiagen-whats-the-plus-in-quantiferon-tb-gold-plus/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/10/Whats-the-Plus-in-QuantiFERON-TB-Gold-Plus..png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181011T110000
DTEND;TZID=America/New_York:20181011T120000
DTSTAMP:20260611T103322
CREATED:20180911T141338Z
LAST-MODIFIED:20180911T141338Z
UID:2705-1539255600-1539259200@resources.govsci.com
SUMMARY:Agilent: Surviving Chromatography Part II Corrective Action
DESCRIPTION:Now you’re lost because your chromatography is not where it should be. What do you do? In this talk we’ll look at ways to troubleshoot what went wrong and discuss things you can do to keep them from happening in the future. \nIn this talk we’ll discuss: \n  \n\nCommon chromatography problems including pressure\, peak shape issues like tailing\, and retention time shifts\nHow to isolate the problem and whether it’s related to chemistry or your instrument hardware/software\nIdentifying the problem and taking corrective action can help prevent the same thing from happening in the future.\n\nREGISTER HERE \n  \nPresenter Information: Jean Lane\, Application Engineer\, Agilent Technologies\, Inc. \nJean has been employed with Agilent since Nov 2010 in technical and applications support and has a primary role supporting Agilent’s full line of LC columns and consumables\, which also includes support for Agilent’s GPC/SEC product line. She came to Agilent thru acquisition of Varian and the former Polymer Laboratories. \nJean has 20 plus years of technical and applications support for both HPLC and GPC consumable products. In addition to practical chromatography experience in the laboratory\, she has had many\, many years in her technical role involving customer support providing assistance and troubleshooting for customer chromatography issues. \n 
URL:https://resources.govsci.com/event/agilent-surviving-chromatography-part-ii-corrective-action/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/09/Surviving-Chromatography-Part-II-Corrective-Action.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181011T110000
DTEND;TZID=America/New_York:20181011T120000
DTSTAMP:20260611T103322
CREATED:20180904T144443Z
LAST-MODIFIED:20190104T150120Z
UID:2605-1539255600-1539259200@resources.govsci.com
SUMMARY:PerkinElmer: Tissue Biomarker Analysis: A Practical Approach for Translational Research
DESCRIPTION:Simultaneous quantitation of 6 or more biomarkers in intact tissue specimens holds the key to many questions concerning the biological basis of health and disease by allowing complex cellular interactions to be captured and analyzed. However\, reliable detection remains elusive due to technical challenges from many sources\, including antibody cross reactivity\, difficulty in balancing signals from rare and abundant targets\, tissue autofluorescence and interference between fluorophores\, especially for co-localized targets. \nIn this webinar application scientists from PerkinElmer will present a practical and validated method for highly multiplexed tissue biomarker analysis that addresses many of these challenges. Opal™ staining is an antibody-agnostic technique\, which produces highly specific and reproducible results and when combined with multispectral imaging systems\, such as Vectra®\, is able to detect eight or more biomarkers simultaneously in one tissue section. Simultaneous detection of multiple antigens on a single tissue with multispectral imaging and analysis reveals spatial relationships between cells with the resolution needed for high-precision proximity analysis and detection of intracellular localization of targeted antigens. By elucidating the relationships between cells\, Opal staining allows you to see intercellular relationships in context of the microenvironment. \nWATCH ON DEMAND \n\n\n\n\n\n\n\n\n\nIn this webinar\, you will learn: \n\nHow to overcome key challenges inherent in multiplex biomarker analysis\nPractical and validated approaches to multiplex IHC staining\nWhy multispectral imaging is important for generating high quality data\nMethods for analyzing relationships between cells\n\n  \n \nGrady Carlson\, PhD\nField Applications Scientist\,\nQuantitative Pathology Solutions\nPerkinElmer \n  \nLinden Wyatt\, PhD\nField Applications Scientist\,\nQuantitative Pathology Solutions\nPerkinElmer
URL:https://resources.govsci.com/event/perkinelmer-tissue-biomarker-analysis-a-practical-approach-for-translational-research/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/09/webinar_header_banner_image_d328f37b7d3968afc867cc5d25576344efeda25f_8579.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181009T140000
DTEND;TZID=America/New_York:20181009T150000
DTSTAMP:20260611T103323
CREATED:20180906T135337Z
LAST-MODIFIED:20180906T135337Z
UID:2631-1539093600-1539097200@resources.govsci.com
SUMMARY:Agilent: Gain Insights into Compliance Trends and Better Prepare for FDA Audits
DESCRIPTION:EVENT OVERVIEW:\nFDA warning letters and 483 observations provide valuable information that can be used to show trends in FDA regulatory focus and changes in auditing practices. Data Integrity has dominated FDA pharmaceutical warning letters in recent years and has harmonized regulators all over the world through common training\, exchange of information\, and collaboration. Analysis of FDA warning letters\, 483 information\, and other regulatory noncompliance data provides a more complete picture of regulatory actions and trends in FDA auditing practices. Laboratories can leverage this insightful regulatory data to understand evolution of FDA thinking and be better prepared for their next FDA audit. \nJoin compliance expert Paul Smith as he reviews where to find valuable non-compliance data\, how to use the data to identify insights\, and trends in FDA auditing practices. \nKEY LEARNING OBJECTIVES: \n\nWhere to access valuable non-compliance data\nHow to best leverage the data to identify insights\nCurrent evolutionary trends in FDA auditing practices\n\nREGISTER HERE \nPRESENTER: \nPaul Smith\nGlobal Strategic\nCompliance Specialist\nAgilent Technologies \n  \nWHO SHOULD ATTEND: \n\nExecutive suite\nLab operations managers (facilities/metrology)\nTechnicians/scientists\nQA/QC managers\nMetrology managers\nQuality director\n\n  \nSponsored by Agilent CrossLab. Presented by LC / GC. \nFor questions contact Kristen Moore at kristen.moore@ubm.com
URL:https://resources.govsci.com/event/agilent-gain-insights-into-compliance-trends-and-better-prepare-for-fda-audits/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/09/Aiglent-Webinar-Gain-Insights-into-Compliance-Trends-and-Better-Prepare-for-FDA-Audits.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181009T130000
DTEND;TZID=America/New_York:20181009T140000
DTSTAMP:20260611T103323
CREATED:20180906T191509Z
LAST-MODIFIED:20181213T133038Z
UID:2643-1539090000-1539093600@resources.govsci.com
SUMMARY:Promega: Bottoms Up: Improving Proteomic Sample Preparation with Recombinant Asp-N and Multi-Enzyme Workflows
DESCRIPTION:While trypsin is the workhorse for bottom-up proteomics\, it is not a magic bullet since tryptic digestion often leaves gaps in protein sequences. In this webinar Dr. Hosfield will describe the advantages of using a new recombinant Asp-N protease to fill in the gaps. He will also demonstrate how combining digests from multiple proteases can yield comprehensive sequence coverage of proteins from a single LC-MS/MS run. \nWATCH ON DEMAND \nADDITIONAL WEBINAR INFORMATION: \nBottom-up mass spectrometry workflows typically use trypsin to digest proteins into peptides suitable for LC-MS/MS analysis. While trypsin is an excellent protease\, alternative proteases are useful for numerous applications including increasing protein sequence coverage and identifying post-translational modifications. \nIn this webinar Dr. Hosfield describes the features of a new recombinant Asp-N protease (rAsp-N). rAsp-N displays both high cleavage efficiency and a strong preference for cleavage N-terminal to aspartic acid. He will explain how this enzyme can be effectively used to digest a variety of sample types\, including complex protein mixtures and therapeutic molecules such as monoclonal antibodies. \nIn addition\, he describes how a multi-enzyme approach can be successfully employed to achieve 100% sequence coverage of an IgG from a single injection. Combining peptides derived from digestion with orthogonal proteases prior to LC-MS/MS analysis could be a general strategy to ensure high sequence coverage while simultaneously reducing demand on instrument time. \nPRESENTER: CHRIS HOSFIELD\nChris Hosfield is a Senior Research Scientist in the Protein Analysis group at Promega. He has lead the development of tools for proteomics and antibody characterization\, including PNGase F\, IdeS\, IdeZ and recombinant Asp-N. \nChris has broad expertise working with proteolytic enzymes and preparing protein samples for analysis by mass spectrometry. Prior to joining Promega\, Chris held senior scientist positions at several biotechnology companies where he applied proteomic methods to the discovery and development of both small molecules and biotherapeutics. He received his PhD in biochemistry from Queen’s University.
URL:https://resources.govsci.com/event/bottoms-up-improving-proteomic-sample-preparation-with-recombinant-asp-n-and-multi-enzyme-workflows/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181004T110000
DTEND;TZID=America/New_York:20181004T120000
DTSTAMP:20260611T103323
CREATED:20181003T144843Z
LAST-MODIFIED:20181003T144843Z
UID:3020-1538650800-1538654400@resources.govsci.com
SUMMARY:Metrohm: Challenges and Solutions for Sugar Analysis in Human Food\, Animal Feed\, and Pet Food
DESCRIPTION:Carbohydrates are an important component of the diet for both humans and animals. Given the recent scientific\, federal and consumer interest in carbohydrates\, specifically in added sugars\, it is important to establish actual sugar profile and composition in human food and beverages\, animal feed\, and pet foods. Sugar profile determination in food matrices helps to understand a product’s consistency and reduces vulnerability to food fraud. Nutritional sugar determination requires proper sample preparation\, matrix elimination\, and optimized separation and detection methods to achieve both precision and accuracy in complex food matrices. \nJoin us for an informational webcast on sugar testing and learn about key drivers for animal and human sugar measurements. Jeff Horst from Agri-King Inc. will discuss recent acceptance of Association of American Feed Control Officials (AAFCO) methods for sugars in animal feed\, pet food\, and human food that establish the initial necessary steps towards an AOAC-approved method for these challenging matrices. Dr. Hari Narayanan from Metrohm USA will discuss the latest developments in sample preparation that support sugar analysis in various human food matrices. \n  \nREGISTER HERE \n  \nKey Learning Objectives: \n\nNew regulations related to sugar analysis in human food\, animal feeds\, and pet foods\nIon chromatography methods for selective and sensitive sugar profiling\nRegulatory drivers for sugar analysis\nNew inline sample preparation techniques to achieve reproducible results\n\n  \nWho Should Attend: \n\nAnalytical development\, QA/QC lab managers from food and beverage companies\, human food\, pet food and animal feed manufacturers\nCommercial testing labs performing food sample analysis\nThose who are interested in learning ion chromatography and sugar analysis applications\nThose who are already using ion chromatography and wants to learn new sample preparation techniques\nAny one from pharmaceutical\, biopharmaceutical interested in learning about carbohydrate and fructans analysis\n\n  \nHave questions? Contact Kristen Moore at\,  \n  \nSPEAKERS \n\nJeff Horst\nLaboratory Production Manager\nAgri-King Inc\n\n\nJeff Horst is the Laboratory Production Manager at Agri-King Inc.\, an International Livestock Nutrition company based in Fulton\, IL. He has spent 28 years at Agri-King Inc.\, the past 17 as Laboratory Production Manager. Jeff is currently a Lab Advisor to Association of American Feed Control Officials (AAFCO) and serving as co-chairman of the Carbohydrate Working Group. He also serves on the National Forage Testing Association (NFTA) Board and is a past president. \n\n\n\nDr. Hari Narayanan\nProduct Marketing Manager\nMetrohm USA Inc\n\n\nDr. Hari Narayanan is the Product Marketing Manager at Metrohm USA Inc. He has eighteen years of experience in analytical chemistry\, focusing on IR\, Raman\, NIR spectroscopy and titration\, ion chromatography\, voltammetry\, XRF and several other analytical techniques. He developed several novel IC applications for the pharmaceutical industry and provided recommendations to USP for IC method updates. He received his B.Sc and M.Sc. in Chemistry from the MK University and a Ph.D. in Analytical Chemistry from the University of Madras\, India.
URL:https://resources.govsci.com/event/metrohm-challenges-and-solutions-for-sugar-analysis-in-human-food-animal-feed-and-pet-food/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/10/Challenges-and-Solutions.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181003T140000
DTEND;TZID=America/New_York:20181003T150000
DTSTAMP:20260611T103323
CREATED:20180926T123445Z
LAST-MODIFIED:20181211T195540Z
UID:2938-1538575200-1538578800@resources.govsci.com
SUMMARY:Optimize Your GC Lab with On-Site Hydrogen Generation
DESCRIPTION:As laboratories and technologies change\, it is important to examine how we supply the gases needed within the laboratory.  This webcast will examine the role of both Hydrogen Lab Servers and benchtop Hydrogen Generators in optimizing your GC laboratory by saving time\, money\, space\, downtime\, headaches\, and in rare cases injury.  In addition\, we will discuss how gas generators can avoid interruptions from lack of availability or delivery issues that can be associated with the use of bottled gases.  This webcast will focus on how on-site Hydrogen Generators provide a steady stream of gas to your GC’s.  We will review advantages of on-site hydrogen gas generation\, including: \n\nCost Savings with minimal changes in expenditure year-after-year\nImprove your GC lab’s efficiency by those handling clumsy gas cylinders (decrease in time wasted)\nMaximizing safety\nDecreased down time with a 24/7\, on-demand\, reliable supply of Hydrogen\nPeace of mind with consistent carrier-grade purity\nBack-up options\n\nWATCH ON DEMAND \nKey Learning Objectives \n\nLearn how hydrogen generators work\nWhich applications are best suited for Hydrogen Gas Generators?\nCommon challenges of gas cylinder delivery and how Hydrogen Generators are the premier technical solution\nEasy installation for both benchtop hydrogen solutions as well as Hydrogen Lab Servers for larger GC applications\n\nWho Should Attend \n\nPetrochemical laboratory directors\nLaboratory managers\nLead Chemists\nGas purchasing agents\nChromatography specialists\nLaboratory personnel for refineries\n\nAttendees of the Live 1 Hour Webinar will receive a Professional Development Seminar Certificate of Completion issued by Proton OnSite. \nSpeaker \nScott Accetta\nRegional Manager\nProton OnSite\n\nScott Accetta is a Regional Manager for Proton OnSite and has been specializing in on-site gas generation solutions for many years.  He has extensive consultative experience in helping GC labs with hydrogen gas generation recommendations that are more cost-effective\, efficient\, convenient\, and safer than traditional delivered gas methods.  His expertise covers a broad range of industries including quality control\, petrochemical\, environmental\, agricultural\, academia\, forensics\, and more.  Scott’s gas generation application knowledge ranges from GC to LCMS and various types of spectroscopy. \n  \nWebinar Sponsored by:
URL:https://resources.govsci.com/event/optimize-your-gc-lab-with-on-site-hydrogen-generation/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/09/Optimize-Your-GC-Lab-with-On-Site-Hydrogen-Generation.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20181003T030000
DTEND;TZID=America/New_York:20181003T160000
DTSTAMP:20260611T103323
CREATED:20180920T162336Z
LAST-MODIFIED:20181211T195448Z
UID:2891-1538535600-1538582400@resources.govsci.com
SUMMARY:Agilent: Elevate the Performance of your GC (and MS): Strategies to Improve Sensitivity and Reliability with Complex Matrix Samples
DESCRIPTION:In an ideal world\, samples would always be clean\, easy to inject and analyse and your GC and MS systems would maintain their sensitivity indefinitely. The reality is that most samples cannot be directly injected onto the GC and MS detection system\, and sample preparation is often needed to achieve the desired sensitivity. Sometimes simple fixes\, such as choosing the right liner\, switching to a high efficiency column\, or utilizing “jet clean” on the MS can make a big difference on the sensitivity of the analysis.  But often\, sample preparation is the critical step needed to get samples ready for GC or GC/MS(-MS) analysis. Appropriate sample preparation techniques not only make samples amenable for GC injection at concentrations suitable for detection\, but also remove and prevent unwanted matrix components from accumulating and deteriorating on the GC and GC/MS flow path. We will discuss useful strategies\, including choosing the right GC column and supplies\, as well as what level of sample preparation\, and maintenance is required for method reliability and analytical data quality\, using challenging representative applications such as PAHs in salmon oil and pesticides in fatty matrices. \nWATCH ON DEMAND \nWhat does it cover? \nGC high efficiency columns and liner selection\, and sample preparation methods/techniques to improve the sensitivity and reliability of your GC and GC/MS analysis. \nBy attending this webinar you will learn: \n\nsome of the strategies you can employ when working with complex matrix samples\nhow to reduce instrument down time due to needed maintenance such as source cleaning\nhow sample preparation can benefit your GC and GC/MS(-MS) analysis.\n\nWhy should you attend? \nTo gain better understanding of: \n\nstrategies that can be implemented when working with complex matrix samples and still maintain the sensitivity and reliability of your GC and GC/MS(-MS) system.\nhow gas quality\, thermal stability\, and column bleed can affect your chromatography.\nsample preparation techniques/methods and their importance to improve method sensitivity and reliability.\n\nPLUS – Participation Bonus: Register and attend the webinar to receive a special offer from Agilent Technologies. \nThis presentation is suitable for… \nLaboratory technicians\, researchers\, and scientists wishing to learn more about how to analyse heavy matrix samples and learn about sample preparation.
URL:https://resources.govsci.com/event/agilent-elevate-the-performance-of-your-gc-and-ms-strategies-to-improve-sensitivity-and-reliability-with-complex-matrix-samples/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/09/Agilent.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180928T110000
DTEND;TZID=America/New_York:20180928T120000
DTSTAMP:20260611T103323
CREATED:20180822T123505Z
LAST-MODIFIED:20180822T123505Z
UID:2436-1538132400-1538136000@resources.govsci.com
SUMMARY:Agilent: Strategically Selecting the Best Superficially Porous Particle LC Column for Your Method Development
DESCRIPTION:Superficially porous particles offer improved efficiency and performance over similarly sized traditional totally porous particles. Higher efficiency leads to improved resolution and possible time savings with superficially porous particles\, hence their popularity for HPLC analyses. Columns using superficially porous particles are available in a wide variety of particle sizes and stationary phase chemistries. This webcast will go into detail on how a chromatographer can exploit new phase chemistries on superficially porous columns. Unique chemistries will be discussed\, including those used for chiral and HILIC separations\, as well as those optimized for long life at elevated pH for improved resolution. \nREGISTER HERE \nKEY LEARNING OBJECTIVES \n\nHow to use the many phase chemistry options available for superficially porous columns as a powerful tool to expedite method development\, including reversed-phase\, chiral\, and HILIC analyses\nHow to use pH to manipulate selectivity of ionizable compounds\nHow to properly set up your LC system and laboratory\, including which superficially porous particle column is best for your current laboratory configuration\n\nWHO SHOULD ATTEND \n\nLab Managers of contract\, government\, or QA/QC labs\nAnalytical chemists who develop methods for small molecule compounds in environmental\, pharmaceutical\, or food samples\nAnalysts and technicians performing analysis of small molecule compounds\nGraduate students and post-docs working\n\nSpeaker: Anne Mack\, Applications Scientist\, Agilent Technologies \n  \nFor questions contact Kristen Moore at Kristen.Moore@ubm.com
URL:https://resources.govsci.com/event/agilent-strategically-selecting-the-best-superficially-porous-particle-lc-column-for-your-method-development/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/08/LCGC-Agilent_092818-Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180927T130000
DTEND;TZID=America/New_York:20180927T140000
DTSTAMP:20260611T103323
CREATED:20180906T194219Z
LAST-MODIFIED:20180906T194219Z
UID:2659-1538053200-1538056800@resources.govsci.com
SUMMARY:Malvern Panalytical: Climate and hydrology studies leveraging ASD VNIR spectral snow albedo measurements
DESCRIPTION:This webinar will discuss snow and ice applications and the use of Malvern Panalytical’s ASD FieldSpec® spectroradiometer for data measurement and analysis. \nREGISTER HERE \nSPEAKER \nDr. Mckenzie Skiles – Assistant Professor University of Utah \nDr. McKenzie Skiles is an Assistant Professor in the Department of Geography at the University of Utah. She holds a PhD in Geography from the University of California – Los Angeles\, an MS degree in Geography\, BS degrees in Geography and Environmental Studies and a GIS certificate – all from the University of Utah. McKenzie is a snow optics specialist\, knowledge which she has applied to one of her main research trajectories; investigating the impacts of mineral dust and black carbon deposition on snow. Additional research interests include mountain and snow hydrology\, snow energy balance\, remote sensing of the cryosphere\, and cryosphere-climate interaction. \n  \nMORE INFORMATION \nWho should attend?\nThose that have interest in snow optics\, and are involved and/ or have interest in snow and ice application studies for climate and environmental monitoring purposes\, and want to learn how the ASD FieldSpec spectroradiometer can be used for data measurement purposes. \nWhy attend?\nTo learn the importance of snow optical property studies for earth system models of climate\, weather\, and hydrology and how the ASD FieldSpec spectroradiometer aids in these studies. \nWhat will you learn? \n\nThe importance of studying snow optical properties and collecting measurements to validate remote sensing retrievals and constrain earth system models for climate\, weather\, and hydrology.\nHow an ASD FieldSpec® spectroradiometer can be used to measure solar irradiance and snow reflectance/albedo\, and how these measurements can be leveraged to retrieve additional snow properties like effective snow grain size and radiative forcing by light absorbing particles.\nHow a drone and other equipment have been paired with the FieldSpec instrument to further advance our understanding of snow energy and mass balance\, with examples from recent field campaigns.
URL:https://resources.govsci.com/event/malvern-panalytical-climate-and-hydrology-studies-leveraging-asd-vnir-spectral-snow-albedo-measurements/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/09/Climate-and-hydrology-studies-leveraging-ASD-VNIR-spectral-snow-albedo-measurements.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180920T130000
DTEND;TZID=America/New_York:20180920T140000
DTSTAMP:20260611T103323
CREATED:20180802T181114Z
LAST-MODIFIED:20180802T181114Z
UID:2094-1537448400-1537452000@resources.govsci.com
SUMMARY:Sakura: BCC\, SCC and Melanoma: Basics and Clinical Correlations
DESCRIPTION:The histology laboratory plays a critical role in the diagnosis and prognosis of skin disease\, and new findings support the vital role of the laboratory as new markers and methods for detecting various pathologies emerge. In this seminar we will review the histological differences in the various different types of skin cancer; focusing on basal cell\, squamous cell\, and melanoma.\n\n\n\n\n\nWe will  discuss the histological findings present in these three types\, and the importance of special stains used to examine these cancers. We will then discuss the current immunohistochemical markers used to differentiate cancer subtypes\, and why immunohistological staining is so important in determining the treatment for these patients\, and protocols for immunohistochemistry for the most common tumor markers. We will also discuss the FDA\, CAP and ASCO requirements and guidelines for IHC staining and antibodies.\n\n\nClick Here to Register\n\n\nRegistration Reminders: \n\nYou must be logged in for the full session in order to receive CEU certificates. \nRegister yourself only once\, do not list yourself as an additional guest. \nCertificates will be sent via email within 2 weeks of the webinar. \nTake care when registering that names are entered exactly as you want them to appear on your certificates and DO NOT put email addresses in name fields.\n\nPresented by Dale Telgenhoff PhD\, MBA\, HTL(ASCP)CM
URL:https://resources.govsci.com/event/sakura-bcc-scc-and-melanoma-basics-and-clinical-correlations/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/08/BCC-SCC-and-Melanoma-Basics-and-Clinical-Correlations.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180919T103000
DTEND;TZID=America/New_York:20180919T113000
DTSTAMP:20260611T103323
CREATED:20180906T193607Z
LAST-MODIFIED:20180906T193607Z
UID:2652-1537353000-1537356600@resources.govsci.com
SUMMARY:Malvern Panalytical: Demo at Your Desk - Epsilon 4
DESCRIPTION:Optimize your processes and comply with stringent international regulations by fast and accurate elemental analysis. Suitable for any industry\, Epsilon 4 is the next step in energy dispersive XRF. \nCombining the latest advances in excitation and detection technology with mature software and a smart design\, the analytical performance of the new benchtop instrument approaches the one of more powerful and floor-standing spectrometers. \nProduct managers Lieven Kempenaers and Michel Zoontjes will demonstrate the new Epsilon 4 during this free webinar. A demonstration shows the ease-of-use\, of the instrument\, from setting up a measurement\, creating dedicated calibrations to analyzing routine samples. Discover what impact the new Epsilon 4 could have on your daily operations. \nREGISTER HERE \nWho should attend?\nAnyone interested in EDXRF \, Lab managers\, quality control specialists\, geologists\, material science and analytical chemistry\, university staff. \nWhy attend?\nTo learn about the benefits of Epsilon XRF benchtops as an elemental analysis technique. Learn how this latest generation technology brings the performance of floor standing systems to the benchtop. \nWhat will you learn?\nThe latest development in EDXRF \,new applications in reach of benchtops +amp;amp; ease-of-use of Epsilon benchtops. \n  \nSPEAKERS \nDr. Lieven Kempenaers – Global Product Manager Benchtop XRF Instruments\nIn 1999 Lieven Kempenaers started his PhD in Chemistry under the direction of Prof. K. Janssens at the University of Antwerp (Belgium) with dedicated focus on the use of X-rays in elemental analysis. In the course of his PhD\, Lieven wrote many articles of which one was awarded as “best article of the year 2000”.\nIn 2003 Lieven completed his PhD in Chemistry and used his XRF knowledge and experience as an XRF Application Specialist and later on as Product Manager for PANalytical\, the Netherlands. In those 5 years he gained more knowledge and experience in many industry segments and the respective applications.\nFrom 2008 until 2012 he was re-located to the Asia Pacific regional head quarters in Singapore and took on the assignment as Asia Pacific Regional Product Manager XRF.\nOnce back in the Netherlands\, he used his Asia Pacific experience as the global product manager for the benchtop XRF instruments. \nDr. Michel Zoontjes – Product Manager EDXRF\nMichel Zoontjes started his PhD in Nanotechnology in 2011 under the direction of Prof. W.G. van der Wiel and Prof. G. Mul at the University of Twente in the Netherland. His subject was visible light water splitting on a chip. In 2015 he received his doctorate degree\, after which he started in 2015 as Product Manager XRF at Malvern Panalytical. He is managing the energy dispersive XRF product line.
URL:https://resources.govsci.com/event/malvern-panalytical-demo-at-your-desk-epsilon-4/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/09/Malvern-Panalytical-Webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180911T110000
DTEND;TZID=America/New_York:20180911T120000
DTSTAMP:20260611T103323
CREATED:20180911T141028Z
LAST-MODIFIED:20180911T141028Z
UID:2701-1536663600-1536667200@resources.govsci.com
SUMMARY:Agilent: Surviving Chromatography Part I Preventive Action
DESCRIPTION:Successful chromatography can be like finding your way through a maze. Planning and good habits can help prevent problems that can take you down the wrong path and cause you to lose your chromatography. In this seminar\, we will look at: \n\nMethod conditions to consider that can make your method robust and rugged. This reduces the chance of method variability and facilitates ease of transfer\nChemistry\, sample prep\, and instrument configuration factors that can affect your HPLC separation Careful attention to method development and care of your instrument saves you the time and aggravation of troubleshooting.\n\n  \n  \nREGISTER HERE \n  \n\nPresenter Information: \nMark Powell\, Application Engineer\, Agilent Technologies\, Inc.\nMark Powell is an Applications Engineer located at Agilent’s Little Falls site in Wilmington\, DE. Before joining Agilent in 2011\, Mark worked in the pharmaceutical industry synthesizing and purifying drug candidates. He provides applications assistance and technical support for Agilent’s HPLC columns and consumables. \nAlex Ucci\, Application Engineer\, Agilent Technologies\, Inc. \nIn his current position at Agilent\, Alex provides application assistance and technical support for sample preparation products and LC consumables. Before he joined Agilent in 2014\, Alex was a graduate student at the Pennsylvania State University researching the morphology and surface properties of aerosol particles using a wide variety of analytical techniques. He has an MS degree in chemistry.
URL:https://resources.govsci.com/event/agilent-surviving-chromatography-part-i-preventive-action/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/09/SURVIVING-CHROMATOGRAPHY-PART-I-PREVENTIVE-ACTION.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180911T110000
DTEND;TZID=America/New_York:20180911T120000
DTSTAMP:20260611T103323
CREATED:20180910T134936Z
LAST-MODIFIED:20180910T134936Z
UID:2686-1536663600-1536667200@resources.govsci.com
SUMMARY:IncuCyte: Live-Cell Analysis of Cell Subsets and Heterogeneity
DESCRIPTION:Our new cell-by-cell analysis module allows users to ‘count and classify’ heterogeneity in cell populations over time.\nThis software uses novel algorithms to segment the HD phase-contrast images which facilitates (1) label-free true cell counting (2) extraction of basic morphological features of individual cells (e.g. size\, shape)\, and (3) measurement of fluorescence intensity that originates from within each cell (‘fluorescence within a phase boundary’). The ability to analyse at a cell-by-cell level will enable the characterisation of subsets and the power to monitor these individual groups in their response to various stimuli. \nREGISTER HERE \nIn this webinar Clare will discuss:\n\nOverview and validation of the cell-by-cell analysis module\nHow cell-by-cell analysis enables monitoring and quantification of dynamic phenotypic changes in heterogeneous populations\nExamples of how the software may be used for cell subset identification in order to provide an end-to-end solution for the study of heterogeneous populations in 96 well format\n\nPresenter: Dr. Clare Szybut\, Senior R&D Scientist\nClare is currently a Senior Scientist at Essen BioScience working within the European based research team where she is involved in the research and development of novel kinetic applications for Essen’s IncuCyte™ live-cell analysis system to expand capabilities. \nShe is a highly experienced cellular biologist with 10 years’ experience.  She gained a PhD in molecular cell biology and has worked in the Biotech industry where she has gained broad technical experience in both biological and biochemical assay design.
URL:https://resources.govsci.com/event/incucyte-live-cell-analysis-of-cell-subsets-and-heterogeneity/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/09/Live-Cell-Analysis-of-Cell-Subsets-and-Heterogeneity.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180911T100000
DTEND;TZID=America/New_York:20180911T110000
DTSTAMP:20260611T103323
CREATED:20180906T191057Z
LAST-MODIFIED:20180906T191703Z
UID:2637-1536660000-1536663600@resources.govsci.com
SUMMARY:Promega: Ask the Experts: Ensuring a Successful PCR Every Time
DESCRIPTION:Do you have questions about PCR? Our Technical Support Scientists Natascha Buter and Joliene Lindholm will be answering all your questions about nucleic acid amplification. Learn more about endpoint PCR and how to make sure you have a successful run every time. \nRegister and submit your questions by August 17 to have the best shot at hearing Natascha and Joliene answer it in the presentation. \nREGISTER HERE \nADDITIONAL WEBINAR INFORMATION: \nWe’ve all had that heartbreaking moment: the UV light turns on and you realize there’s no band where your target sequence should be. PCR issues can ruin your day and set you back in your project\, but our Technical Support Scientists are here to help. \nIn this live webinar\, amplification experts Natascha Buter and Joliene Lindholm will answer all your questions about PCR optimization and troubleshooting. \n  \nPRESENTERS: Natascha Buter\, MS and Joliene Lindholm\, PhD \n\nJoliene Lindholm\, PhD –  Joliene is a Technical Services Scientist at Promega Corporation based in Madison\, WI. She received a B.S. in Molecular Biology from Montana State University and her PhD in Entomology from the University of Wisconsin-Madison. As a graduate student\, Joliene worked to elucidate the molecular mode of action of the insect juvenile hormone using fruit flies as a model organism. The Technical Services Scientist role provides her the opportunity to utilize her 10+ years of laboratory experience in molecular and biochemistry techniques to advance the scientific endeavors of customers. She specializes in the Promega product areas of Biologics and Mass Spectrometry. She says “The best thing about my job is learning about all the interesting projects that scientists are investigating; this is always something new and exciting and I get to help them succeed in their goals.” \nNatascha Buter\, MS – Natascha is a Technical Services Scientist at Promega Corporation based in Madison\, WI. She received her BS in Molecular\, Cellular\, and Developmental Biology from the University of Colorado\, Boulder and her MS in Biochemistry from the University of Wisconsin-Madison. During her graduate work and later as a lab scientist\, Natascha focused her work on elucidating how mRNAs are regulated via their 3’UTRs. She used fungi\, worms\, fruit flies\, and mice as model organisms. Her broad experience in many molecular techniques is very useful in supporting customers as a Technical Services Scientist. She specializes in the Promega product areas of Biologics and Detection Instruments. She especially enjoys interacting with customers coming from many different scientific backgrounds\, from high school students to veteran PIs to senior researchers in the private industry.
URL:https://resources.govsci.com/event/ask-the-experts-ensuring-a-successful-pcr-every-time/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180808T080000
DTEND;TZID=America/New_York:20180808T170000
DTSTAMP:20260611T103323
CREATED:20180808T123109Z
LAST-MODIFIED:20180808T185728Z
UID:2151-1533715200-1533747600@resources.govsci.com
SUMMARY:Axion: RESTORING FRAGILE X FUNCTION WITH GENE EDITING
DESCRIPTION:Fragile X syndrome is the most prevalent genetic form of intellectual disability with an incidence of one in 4\,000. Patients with Fragile X syndrome display a broad spectrum of autistic phenotypes that range from mild to severe intellectual\, social\, and reasoning deficits. This disorder stems from the loss of the Fragile X mental retardation protein\, FMRP\, an RNA binding protein which is essential for synaptic function. Currently\, there is no cure or treatment for Fragile X syndrome due in part to the complexity in the Fragile X syndrome neuronal circuitry. \nIn this Coffee Break Webinar\, Dr. John Graef (Fulcrum Therapeutics) demonstrates how using CRISPR gene-editing and patient-derived cells Fulcrum can create the Fragile X syndrome phenotype in a dish. Moreover\, this approach has enabled an estimate of the level of FMRP protein expression required to correct the observed Fragile X syndrome phenotype. \nWatch On Demand
URL:https://resources.govsci.com/event/restoring-fragile-x-function-with-gene-editing/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/08/Axion-RESTORING-FRAGILE-X-FUNCTION-WITH-GENE-EDITING.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180725T130000
DTEND;TZID=America/New_York:20180725T140000
DTSTAMP:20260611T103323
CREATED:20180712T132058Z
LAST-MODIFIED:20180717T122052Z
UID:1459-1532523600-1532527200@resources.govsci.com
SUMMARY:Leica: Mitigating Risk and Improving Patient Safety – Identify and Eliminate Defects Prior to Stain Review
DESCRIPTION:Overview \nThere has always been pressure on the Histology Lab to do more with less money\, less people and less time. Automation in Histology has somewhat stalled over the past few years and is difficult to implement. Automation is only a multidisciplinary process to integrate manufactured machinery and software to perform manual tasks that will allow the lab to capitalize on technology that will provide new and improved processes\, increased quality and\, most importantly\, improved patient safety. The continued evolution of innovation in Histology\, both sustaining and disruptive\, has taken us from inferior processes to replacement with superior processes. So\, why are these processes so critical to success? Developing Innovative Solutions is a demand of the patient and embraced by your management. This workshop will provide learnings/ outcomes from implementation projects and identify opportunities for success and will provide the attendee a new understanding of how automation/ innovation can move your lab from niche application to integrated process. \nREGISTER HERE \nLearning Objectives: \n\nIdentify opportunities for automation\nFormulate automation/innovation solutions\nDevelop improvement processes\n\nPresenter:\nWilliam N. DeSalvo III has 40+ years of experience in the Anatomic Pathology field\, 36 years as a Registered Histotechnologist (HTL) by the American Society for Clinical Pathology (ASCP)\, 11 years as a Clinical Histology Laboratory consultant and 12 years as a Product/Marketing Manager. He earned a degree in Biology/Chemistry from Southeast Missouri State University\, received training in Six Sigma and LEAN methodologies for process improvement\, an active practitioner of continuous process improvement\, process improvement consultant and has developed a Quality Management System for the Histology and Anatomic Pathology laboratories. For the past 15 years\, he has provided educational presentations and published multiple articles on process improvement\, standardization and automation in the Histology laboratory to organizations and laboratories located in the USA\, Canada\, Europe\, Japan\, South Africa and Russia. He is currently working as an Anatomic Pathology System Manager\, Consultant\, Editorial Staff Member (Clinical Laboratory Products)\, Clinical Coordinator and Adjunct Faculty for the Applied Sciences Histotechnology Program for Phoenix College and has previously volunteered as an Executive Board Member and Membership Committee Chair (Digital Pathology Association).
URL:https://resources.govsci.com/event/mitigating-risk-and-improving-patient-safety-identify-and-eliminate-defects-prior-to-stain-review/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180725T090000
DTEND;TZID=America/New_York:20180725T100000
DTSTAMP:20260611T103323
CREATED:20180723T185814Z
LAST-MODIFIED:20180723T185847Z
UID:1636-1532509200-1532512800@resources.govsci.com
SUMMARY:Qiagen: miRNA qPCR for Challenging Samples
DESCRIPTION:MicroRNAs (miRNAs)\, small non-coding RNAs that regulate gene expression\, hold incredible promise as minimally invasive biomarkers for use in the diagnosis and prognosis of a wide range of diseases and biological processes. miRNAs are transported in body fluids within exosomes\, thus making them ideal biomarkers due to their stability and the ease with which they can be obtained. However\, special challenges exist for miRNA analysis\, including the short length of miRNAs\, their divergent sequences and variable GC content\, as well as a their low abundance in biofluids. Nonetheless\, the stable nature of miRNAs makes these short 21-23 nt molecules ideal for use as biomarkers of cancer and disease states. A highly sensitive\, specific\, and accurate analysis method that allows linear detection of miRNA even at very low concentrations is\, therefore\, essential for their study. \nThis webinar discusses the important considerations of miRNA analysis when working with challenging sample types. Use of Locked Nucleic Acid (LNA®) technology is proving instrumental for success in these situations. Discover how LNA® technology\, an integral part of the miRCURY LNA miRNA PCR System\, deals with challenging clinical biofluid samples and learn about the importance of quality control and data analysis in your PCR experiment. \nREGISTER HERE
URL:https://resources.govsci.com/event/qiagen-mirna-qpcr-for-challenging-samples/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/07/miRNA-qPCR-for-Challenging-Samples.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180720T080000
DTEND;TZID=America/New_York:20180720T170000
DTSTAMP:20260611T103323
CREATED:20180808T184803Z
LAST-MODIFIED:20180808T185751Z
UID:2177-1532073600-1532106000@resources.govsci.com
SUMMARY:Axion: SCREENING FOR ENVIRONMENTAL TOXINS WITH A HUMAN BRAIN IN A DISH MODEL
DESCRIPTION:In our daily lives we are exposed to thousands of commercially used chemicals. Many of these chemicals are not toxic at typical exposure levels\, but for thousands of chemicals\, toxicological information is lacking. The National Academy of Sciences report on ‘‘Toxicity testing in the 21st century’’ highlighted the need for efficient methods to screen chemicals (e.g. insecticides) for their potential to cause toxicity. \nWhen screening compounds for the potential to disrupt the nervous system\, measuring neural activity is crucial\, since many neurotoxins are known to disrupt ion channel\, and receptor activity in the absence of other biochemical or structural changes to the cell. In this Coffee Break Webinar\, Dr Lorena Saavedra (NeuCyte) discusses how measuring compound-induced changes to the spontaneous firing activity of human stem cell-derived neural cells in an MEA assay helped detect potentially harmful neurological side effects of compounds such as pyrethroid insecticides. \nWatch On Demand
URL:https://resources.govsci.com/event/screening-for-environmental-toxins-with-a-human-brain-in-a-dish-model/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/08/Axion-SCREENING-FOR-ENVIRONMENTAL-TOXINS-WITH-A-HUMAN-BRAIN-IN-A-DISH-MODEL.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180711T100000
DTEND;TZID=America/New_York:20180711T110000
DTSTAMP:20260611T103323
CREATED:20180621T162933Z
LAST-MODIFIED:20180709T132731Z
UID:912-1531303200-1531306800@resources.govsci.com
SUMMARY:Eppendorf: Culture of 3D Cell Aggregates in Perfusion
DESCRIPTION:Three-dimensional (3D) cell aggregates are of great interest for many applications\, including disease modeling\, drug toxicity assessment\, and manufacture of stem cell-based products. Stirred-tank bioreactors are promising culture systems for 3D cell aggregates\, as they allow efficient establishment and maintenance of cell aggregates\, process monitoring and control\, and process scale-up to larger volumes. Furthermore\, they can be operated in perfusion mode\, which allows 3D cell aggregates to be sustained longer than in traditional batch cultures.\n\nThis webcast will review a research example for process development with the human tumor cell line H157\, cultivated in stirred-tank mini bioreactors as 3D cell aggregates. \n\n\nRegister Here \n\n\n\nLearning Objectives: \n\nLearn about the challenges and benefits of perfusion cultivation for stem cells and 3D cell models\nGain insight on the impact of impeller geometry on cell growth and aggregate formation\nInteract with an expert in a live Q&A session\n\n\nNorth America | Europe Broadcasts:\nWednesday\, July 11\, 2018 at 10am EDT | 9am CDT | 3pm BST | 4pm CESTAsia Pacific Broadcast:\nWednesday\, July 11\, 2018 at 11:30am IST | 2pm CST | 3pm JST \n\n\n\n\n\nSpeaker:\nDr. Philipp Nold\, Infield Application Specialist\, Eppendorf Bioprocess Center\, Juelich\, Germany
URL:https://resources.govsci.com/event/culture-of-3d-cell-aggregates-in-perfusion/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/06/Culture-of-3D-Cell-Aggregates-in-Perfusion.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180629T110000
DTEND;TZID=America/New_York:20180629T120000
DTSTAMP:20260611T103323
CREATED:20180618T174824Z
LAST-MODIFIED:20180709T132622Z
UID:797-1530270000-1530273600@resources.govsci.com
SUMMARY:Agilent: Quantitation and Profiling Metabolomics and Translation to Clinical Analysis
DESCRIPTION:Measurement of these metabolites represents the digital readout of health.  A key aspect of metabolomics is the utilization of high resolution mass spectrometric approaches to detect and identify metabolites from biological fluids and tissues.  The use of multi-analyte analyses as well as high resolution mass spectrometric approaches has the potential to transform clinical diagnostics for the next generation. This presentation will discuss profiling and quantitative metabolomics techniques such as traditional LC-MS based approaches and new methods that utilize direction analysis approaches. \nLearning Objectives: \n\nDemonstrate the use of multianalyte metabolomic panels in clinical research\nDiscuss the application of high resolution mass spectrometry approaches to metabolomics\nUnderstand the utilization of bioinformatic tools for interpreting results.\n\nWatch Webinar on Demand \nFor Research Use Only. Not for use in diagnostic procedures \nCONTINUING EDUCATION CREDITS: P.A.C.E. CE | Florida CE \n \n  \nTimothy J Garrett\, PhD\nAssociate Professor\, University of Florida
URL:https://resources.govsci.com/event/quantitation-and-profiling-metabolomics-and-translation-to-clinical-analysis/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Agilent-Webinar-June-29.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180620T150000
DTEND;TZID=America/New_York:20180620T160000
DTSTAMP:20260611T103323
CREATED:20180614T232032Z
LAST-MODIFIED:20180709T132528Z
UID:747-1529506800-1529510400@resources.govsci.com
SUMMARY:Qiagen: Rethinking TB Testing and Treatment in Pediatrics
DESCRIPTION:Join Dr. Sonia Qasba for a live interactive webinar event! \nOn June 1st\, the American Academy of Pediatrics released the new Red Book® 2018 edition\, which expands established AAP recommendations for TB blood testing in children. The AAP now preferentially recommends the use of TB blood tests (IGRAs) in BCG-vaccinated children aged 2 years and older.  \nJoin us for a live webinar event to learn more about the new AAP guidelines. During this program\, you’ll learn more about the rationale behind the new pediatric IGRA recommendations and LTBI treatment regimens\, while looking more broadly at how TB elimination efforts are increasingly focused on employing preventive methods in the primary care setting. \nView Webinar on Demand \n  \nPresenter:\nSonia Qasba\, MD\nSuburban Hospital\, part of Johns Hopkins Medicine
URL:https://resources.govsci.com/event/rethinking-tb-testing-and-treatment-in-pediatrics/
LOCATION:From your desktop or mobile device
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Rethinking-TB-testing-and-treatment-in-Pediatrics.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180620T090000
DTEND;TZID=America/New_York:20180620T190000
DTSTAMP:20260611T103323
CREATED:20180619T193814Z
LAST-MODIFIED:20180709T132144Z
UID:838-1529485200-1529521200@resources.govsci.com
SUMMARY:Teledyne CETAC: An Introduction to the All New SimPrep Automated Liquid Handling Station
DESCRIPTION:The webinar will be presented three different times so be sure to select the appropriate time slot when registering on the registration page \n\n\n9:00 AM EDT / 8:00 AM CDT /  7:00 AM MDT / 6:00 AM PDT / 3:00 PM BST/ 5:00 PM IDT / 9:00 PM CST / 10:00 PM JST \n\n\n3:00 PM EDT / 2:00 PM CDT / 1:00 PM MDT / 12:00 Noon PDT / 8:00 PM BST / 10:00 PM IDT / 3:00 AM CST / 4:00 AM JST \n\n\n7:00 PM EDT / 6:00 PM CDT / 5:00 PM MDT / 4:00 PM PDT / 12:00 Midnight BST / 2:00 AM IDT / 7:00 AM CST / 8:00 AM JST \n\n\nCombining a Cetac Autosampler with a Hamilton Dual Syringe dilution system brings an all new fully automated prep station to the market. With Hamilton accuracy and Cetac reliability the SimPrep gives the best performance in the market for sample preparation. \n This system does more than simply dilute samples. In addition to dilutions the SimPrep can dispense\, mix\, spike samples\, do serial dilutions\, split samples for multiple preps\, and even prepare your calibration standards. \n\nRequest On Demand Webinar \n  \nJacob Herrington\, Teledyne CETAC Product Manager will be presenting this webinar.  \nThe presentation will last approximately 30 minutes and will include a question and answer session to follow
URL:https://resources.govsci.com/event/an-introduction-to-the-all-new-simprep-automated-liquid-handling-station/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Teledyne.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20180620T080000
DTEND;TZID=America/New_York:20180620T170000
DTSTAMP:20260611T103323
CREATED:20180808T185624Z
LAST-MODIFIED:20180808T185709Z
UID:2180-1529481600-1529514000@resources.govsci.com
SUMMARY:Axion: PRECISION MEDICINE - EXTINGUISHING THE FIRE OF THE BURNING MAN
DESCRIPTION:“Man on Fire” syndrome\, also known as Inherited Erythromelalgia (IEM)\, is a chronic pain syndrome characterized by burning pain in the hands and feet. The chronic pain of most patients with IEM cannot be relieved by common pain killers making this disease a major unmet medical need. \nPrecision Medicine is an approach that tailors the prescribed medical treatment to the individual’s genetic makeup. In this Coffee Break Webinar\, Dr Yang Yang (Purdue University) discusses advances in the treatment of IEM using a pharmacogenomic approach. The drug responsiveness of different genetic mutations associated with IEM were probed in an in vitro Maestro MEA assay\, with the results helping to predict the effective treatment of these IEM patients in the clinic. \nThis precision medicine approach\, guided by genomic analysis and functional profiling\, provides a promising new way to extinguish the fire of the burning man. \nWatch On Demand
URL:https://resources.govsci.com/event/precision-medicine-extinguishing-the-fire-of-the-burning-man/
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180619T120000
DTEND;TZID=UTC:20180619T130000
DTSTAMP:20260611T103323
CREATED:20180613T182457Z
LAST-MODIFIED:20180712T125505Z
UID:632-1529409600-1529413200@resources.govsci.com
SUMMARY:Leica Biosystems: Identifying Respiratory Disease in Pathology
DESCRIPTION:Identifying respiratory pathology will look at the entire spectrum of making a pathology diagnosis. We will start by explaining various specimen collection methods. Once the specimen is collected and processed in histology or cytology\, this presentation will look at different staining techniques and IHC/molecular methods used to make a diagnosis. The presentation will conclude with a few case studies that will incorporate the presentation to diagnosis of a respiratory condition. \nWe will cover the following webinar learning objectives: \n\nLearn the types of cells found in respiratory pathology.\nUnderstand proper specimen collection methods.\nIdentify IHC stains and molecular techniques used in common diagnoses.\n\n  \nWatch Webinar on Demand \n  \nAllison Eck is the lead histotechnologist at Doylestown Hospital in Pennsylvania. She has been a histotechnologist for 15 years after graduating with a degree in histotechnology from Harford Community College in Maryland and a bachelor’s degree in biology from Lycoming College in Pennsylvania. She holds her histotechnologist (HTL) and qualification in laboratory safety (QLS) certifications through the ASCP\, as well as her Allied Health Instructor (AHI) certification through AMT. Allison has spoken at a variety of professional conferences on respiratory disease as well as lab safety and ergonomics. \n  \n 
URL:https://resources.govsci.com/event/identifying-respiratory-disease-in-pathology/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Pathology-Leaders.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180614T100000
DTEND;TZID=UTC:20180614T110000
DTSTAMP:20260611T103323
CREATED:20180612T192729Z
LAST-MODIFIED:20180709T130951Z
UID:615-1528970400-1528974000@resources.govsci.com
SUMMARY:Panel discussion on large molecule quantification by LC–MS
DESCRIPTION:The increasing importance of large molecule therapeutics has been coupled with advancements in LC–MS technology\, opening up new opportunities. Typically\, large molecules are analyzed using ligand-binding assays but with advanced progress in MS technology the community has seen increased success in overall sensitivity and selectivity. However\, what does this mean for future analysis and what challenges remain for the use of LC–MS for large molecules. \nIn this free panel discussion\, our experts will provide insights into their own research with large molecules including the challenges they have had to overcome\, key trends they have seen and their future outlook of the development of this field. There is also an opportunity for your own questions to be answered in the live Q&A. \nWhat will you learn? \n\nBest practices of protein quantification and digestion\nConsiderations for Top-down vs Bottom-up approaches\nFuture developments (including enhancing assay sensitivity)\n\nWatch Webinar on Demand \nSpeakers\n\n\n\n\nMichael Blackburn\nBioanalytical Scientist\, Method Development\nARCINOVA (Alnwick\, UK)\n\n\nMichael completed postgraduate work at the University of Wales (Bangor\, UK) and began work for the government in the UK\, measuring the concentrations of pollutants in aquatic samples by gas and later liquid chromatography-mass spectrometry. He later joined the pharmaceutical industry with Sanofi (Guildford\, UK)\, as a mass spectrometrist\, doing bioanalytical and drug metabolism studies. Since then he has worked as a Principle Investigator and Head of Method Development at Covance (Alnwick\, UK) and latterly for ARCINOVA as a method developer. The development of better insulin assays using hybrid MS approaches has been a major interest for about 10 years. \n\n\n\n\n\nKees Bronsema\nSenior Scientist\nPRA (NC\, USA)\n\n\nKees Bronsema\, Senior Scientist in Bioanalytical Method Development LC–MS/MS at PRA (Groningen\, Netherlands)\, has nearly 20 years of experience in the field. Initially\, the focus was on small molecule quantitation but following the trend towards biopharmaceuticals\, he completed postgraduate work on absolute quantitation of proteins and peptides with LC–MS/MS at the University of Groningen (Groningen\, Netherlands) in 2015. His current role is to develop analytical methods for proteins and peptides with LC–MS/MS\, which include both endogenous biomarkers and biopharmaceuticals. \n\n\n\n\n\nCory E. Muraco\nSenior R&D Scientist\nMilliporeSigma (MA\, USA)\n\n\nCory is a Senior R&D Scientist in the Liquid Separations R&D group at MilliporeSigma\, Bellefonte\, PA. He completed his graduate studies at Youngstown State University in 2013\, focusing on the analysis and characterization of oxidized proteins. Upon graduation\, Cory joined MilliporeSigma in 2013\, first joining the chemical standards R&D group\, then transferring to the liquid separations R&D group. His current role at MilliporeSigma is to research\, develop\, and present on new particle technology for improved chromatographic separations of both small and large molecules as well as to develop new methodologies for characterizing biomacromolecules by several modes of chromatography. \n*The life science business of Merck KGaA\, Darmstadt\, Germany operates as MilliporeSigma in the U.S. and Canada. \n\n\n\n\n\nOmnia A. Ismaiel\nSenior Research Scientist\nPPD (NC\, USA)\n\n\nDr Omnia Ismaiel is a Senior Research Scientist at Bioanalytical Labs\, Pharmaceutical Product Development\, USA. She is also an Associate Professor of Pharmaceutical Analytical Chemistry at Faculty of Pharmacy (Zagazig University\, Egypt) and Affiliate Assistant Professor at School of Pharmacy (Virginia Commonwealth University\, VA\, USA). She was a Postdoctoral Fellow at Virginia Commonwealth University and a Postdoctoral Research Associate at University of Georgia\, USA. She has been in the Bioanalysis field for more than 12 years. and has many years of teaching experience too. She is currently working on development and validation of Bioanalytical LC–MS methods for therapeutic peptides/proteins\, glycan analysis and high-resolution MS. \n\n\n\n\n\nRobert Wheller\nPrincipal Scientist\nLGC (Cambridge\, UK)\n\n\nRobert is a principal scientist at LGC where he leads of a group of scientists focused on providing a large molecule LC-MS bioanalytical service. He has expertise in the bioanalysis of small molecules\, oligonucleotides\, peptides and proteins utilizing LC-MS/MS and ligand binding assay technologies. He has developed a keen interest in the implementation of immunoaffinity\, 2D-LC and HR-MS techniques for protein LC-MS quantification workflows. \n\n\n\n\n\nHongbin Yu\nDirector\nBoehringer Ingelheim Pharmaceuticals\n\n\nHongbin Yu is the Director of Bioanalytical Mass Spectrometry in the DMPK department at Boehringer Ingelheim Pharmaceuticals in Ridgefield (CT\, USA). He obtained his Ph.D in organic chemistry from the University of Missouri-Columbia (MO\, USA). He joined Boehringer Ingelheim in 2006 and has supported drug development for both small and large molecules. For small molecules\, his responsibilities focused on biotransformation and bioanalysis utilizing LC–MS. For large molecules\, his responsibilities included supervising immunoassay development/validation\, critical reagent generation and pharmacokinetic analysis. He currently oversees regulated and non-regulated bioanalysis for small molecules by LC–MS and large molecules by hybrid LBA/LC–MS.
URL:https://resources.govsci.com/event/panel-discussion-on-large-molecule-quantification-by-lc-ms/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://resources.govsci.com/wp-content/uploads/2018/06/Webinar-Large-Molecule-Quantification-by-LC-MS.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20180523T083000
DTEND;TZID=UTC:20180523T153000
DTSTAMP:20260611T103323
CREATED:20180529T193410Z
LAST-MODIFIED:20180709T130441Z
UID:492-1527064200-1527089400@resources.govsci.com
SUMMARY:Horiba: A Seminar on the Newest Breakthroughs in Nanoparticle Measurements
DESCRIPTION:HORIBA Instruments and Microfluidics present a seminar on the newest breakthroughs in nanoparticle measurements \n\n\nWednesday\, May 23rd\, 2018\n\nHoliday Inn Gaithersburg\n2 Montgomery Village Ave\nGaithersburg MD 20879\n301-948-8900 \n\nMarinella Sandros\, Ph. D.\, Horiba Scientific will present “Designed Nano-Bio interfaces using Surface Plasmon Resonance imaging for Biomedical Application.” \nNew Technology for the Formulation and Characterization of Mono & Polydisperse Nanomaterials for the Pharma\, Biotech Extracellular Vesicle\, and Virology Markets\nRequest recording from carol.madden@horiba.com | P: 800-446-7422 x 1133 | F: 949-468-1790  \nFeaturing guest speakers and acknowledged experts: \n• Jeffrey D. Clogston\, Ph.D – Leidos Biomedical Research\n• Jan “Kuba” Tatarkiewicz\, Ph.D – MANTA Instruments\n• Pushpendra Singh\, Ph.D – WRAIR\n• Niaz Khan – University of Maryland\n• Philo Morse – Particle Sciences\n• Gary R. Matyas\, Ph.D – WRAIR\n• Andrew Lees\, Ph.D – Fina Biosolutions LLC \nEmphasis of the seminar will be on applications\, problem solving and new developments in nanoparticle sciences. The ViewSizer® 3000 and LA-960 instruments\, and MicroFluidizer technology will be featured.
URL:https://resources.govsci.com/event/a-seminar-on-the-newest-breakthroughs-in-nanoparticle-measurements/
LOCATION:Holiday Inn Gaithersburg\, 2 Montgomery Village Ave\, Gaithersburg\, MD\, 20879\, United States
CATEGORIES:Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20170919T080000
DTEND;TZID=America/New_York:20170919T170000
DTSTAMP:20260611T103323
CREATED:20180702T224830Z
LAST-MODIFIED:20180709T130344Z
UID:1157-1505808000-1505840400@resources.govsci.com
SUMMARY:Essen BioScience: Quantitative Live-Cell Analysis of Human iPSC-derived Neurons
DESCRIPTION:Optimization of culture conditions and evaluation of cell health \nWatch Recording On Demand \nA major limitation in studying human diseases affecting the nervous system is the ability to culture\, monitor and analyze neuronal cells that accurately represent human phenotypes of these disorders. The use of human induced pluripotent stem cell (hiPSC)-derived neurons has provided a new approach aimed at modeling neurological diseases. Monitoring neuronal morphology and cell health in long-term culture is critical for the characterization and evaluation of these novel model systems. Traditional approaches rely on endpoint assays and imaging techniques that require immunochemical staining\, which provide limited real-time kinetic information. In this webinar\, we highlight optimal culture conditions and demonstrate the ability of the IncuCyte S3® approach for real-time\, long-term quantitative analysis of iPSC-derived neuronal cell health. \nWatch this webinar to learn how:  \n\nYou can easily optimize culture conditions for (hiPSC)-derived neurons\nReal-time live-cell analysis using phase (monoculture) or fluorescent (co-culture) NeuroTrack software can be used to visualize and quantify neurite dynamics\nOther live-cell phenotypic assays (e.g. apoptosis) are used to monitor neuronal cell health and validate mechanisms of action\n\nSpeaker: Aaron Overland | Senior Application Scientist\, Essen BioScience \nAaron joined Essen BioScience as a Senior Application Scientist in September of 2016 and is leading projects focused on developing new reagents and applications for live cell analysis of neuronal health and function using the IncuCyte system. Aaron earned his BS and PhD in Neuroscience from the University of Minnesota\, where he investigated cellular signaling mechanisms mediating analgesic synergy between agonists acting at delta-opioid and alpha2-adrenergic receptors in the spinal cord. His postdoctoral work at University of California\, San Diego expanded upon his foundation in cell-based assays of G protein-coupled receptor signaling\, focusing on the discovery of a novel signaling module for G protein-mediated transactivation of EFGR in cardiomyocytes and fibroblasts.
URL:https://resources.govsci.com/event/quantitative-live-cell-analysis-of-human-ipsc-derived-neurons/
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://resources.govsci.com/wp-content/uploads/2018/07/Quantitative-Live-Cell-Analysis-of-Human-iPSC-Derived-Neurons.png
END:VEVENT
END:VCALENDAR